Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-006001

Chief Financial Officer bought 27,000 shares at $1.27 ($34,177)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-22 Purchase : show line 1 in the form +27,000 $1.27 $34,177 36,772 D
Open-market purchases · 27,000 sh · avg $1.27 · $34,177
Loading xslF345X05/ownership.xml…